Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors.

ABSTRACT:

Purpose

Adjuvant endocrine therapy reduces the recurrence and mortality of early hormone receptor-positive breast cancer in both pre- and postmenopausal women. The aim of this study was to investigate adjuvant tamoxifen adherence and associated factors in breast cancer survivors.

Methods

This descriptive, prospective study was conducted in 2019-2020 with the participation of 531 women who survived breast cancer and were under follow-up at the Senology Institute of a hospital in Istanbul. Inclusion criteria were having completed treatment for early hormone receptor-positive breast cancer, being prescribed tamoxifen, and being 18 years or older. Data were collected using a patient information form and the Morisky Medication Adherence Scale-8 (MMAS-8).

Results

The mean a

SUBMITTER: Uslu Y 

PROVIDER: S-EPMC10116476 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature